loader

World Tenders & Procurement Opportunities

Search
Advanced Search

252511- Germany – Pharmaceutical products – Open House Originale Rabattverträge 2025-13 - Fluticason, Umeclidinium, Vilanterol (Wirkstoffkombination)

World Biggest Tenders Source

This tender with title 252511- Germany – Pharmaceutical products – Open House Originale Rabattverträge 2025-13 - Fluticason, Umeclidinium, Vilanterol (Wirkstoffkombination) has been published on Bidding Source portal dated 21 Apr 2025 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

General Information

Germany

252511- Germany – Pharmaceutical products – Open House Originale Rabattverträge 2025-13 - Fluticason, Umeclidinium, Vilanterol (Wirkstoffkombination)
Invitation for Bids
252511
Germany
21 Apr 2025
31 May 2027
English
Pharmaceutical products

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

252730- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Tianeptin, ATC N06AX14 für die Zeit 01.06.2025 - 31.05.2027 (zzgl. Verlängerungsoption 1x12 Monate) Germany 252845- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Erythropoietin, ATC B03XA01 für die Zeit 01.06.2025 - 31.05.2027 (zzgl. Verlängerungsoption 1x12 Monate) Germany 255277- Germany – Pharmaceutical products – Abschluss nicht exkl. AM-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Glatirameracetat in der Darreichungsform PEN (ATC-Code nach WHO: L03AX13) Germany 254836- Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Interferon beta-1a (ATC-Code nach WHO: L03AB07) Germany 255489- Germany – Pharmaceutical products – Open-House-Rabattverträge 2025-05 Germany 251141- Germany – Pharmaceutical products – Arzneimittelverträge mit Beitrittsoption Germany 250377- Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge gemäß § 130a Abs. 8c SGB V Trastuzumab, ATC L01FD01 Germany 250251- Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge gemäß § 130a Abs. 8c SGB V Bevacizumab, ATC L01FG01 Germany 250044- Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge gemäß § 130a Abs. 8c SGB V Rituximab, ATC L01FA01 Germany 249452- Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Risperidon in der Darreichungsform Pulver und Lösungsmittel zur Herstellung einer Injektionslösung, ATC N05AX08 Germany
Pharmaceutical products Tenders
Germany Tenders
Europe Tenders
Tenders
No. 12, 1 st floor, Block B2, EGS Business Park, World Trade Center, Bakirkoy - Istanbul - Turkey
info@biddingsource.com
24 X 7 online support
TOP
For viewing latest tenders published for your business in all over the World: Sign in Join free
For accessing full details of Tenders, Kindly choose the Plan that works for you: View Subscription Plans